Cargando…
Antiresorptive agent-related osteonecrosis of the jaw in osteoporosis patients from Asian countries
Bisphosphonate (BP)-associated osteonecrosis of the jaw (ONJ) was first reported in oncology patients in 2003 and subsequently in osteoporosis patients in 2004. Since oral surgical procedures, such as tooth extraction, are also considered one of the major risk factors for ONJ, there is confusion amo...
Autores principales: | Taguchi, Akira, Shiraki, Masataka, Morrison, Archie, Khan, Aliya A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Osteoporosis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372774/ https://www.ncbi.nlm.nih.gov/pubmed/30775507 http://dx.doi.org/10.1016/j.afos.2017.03.001 |
Ejemplares similares
-
Treatment of osteonecrosis of the jaw related to bisphosphonates
and other antiresorptive agents
por: Rodriguez-Lozano, Francisco-Javier, et al.
Publicado: (2016) -
Relationship between drug holiday of the antiresorptive agents and surgical outcome of medication-related osteonecrosis of the jaw in osteoporosis patients
por: Morishita, Kota, et al.
Publicado: (2022) -
Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS
por: Anastasilakis, Athanasios D, et al.
Publicado: (2021) -
Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (4), CT and MR imaging findings of antiresorptive agent-related osteonecrosis of the jaws/medication-related osteonecrosis of the jaw (secondary publication)()
por: Baba, Akira, et al.
Publicado: (2019) -
Incidence and trend of antiresorptive agent-related osteonecrosis of the jaw from 2016 to 2020 in Kure, Japan
por: Kunihara, Takahiro, et al.
Publicado: (2023)